[
  {
    "criterion": "Provides a detailed explanation of bridging therapy and its relation to atrial fibrillation and moderate mitral regurgitation.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Mentions the importance of considering the patient's individual circumstances and medical history when deciding on bridging therapy.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Uses technical jargon and medical terminology correctly and in context.",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Incorrectly suggests that bridging therapy is only necessary for patients with severe mitral regurgitation.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Does not address the potential risks and complications associated with bridging therapy.",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Provides a clear and concise summary of the conversation, highlighting the key points and recommendations.",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Fails to provide any relevant references or sources for the information provided.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Incorrectly states that the CHA2DS2-VASc score is the only relevant risk model for patients with atrial fibrillation.",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Does not address the potential need for further evaluation or testing before starting bridging therapy.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Provides a clear and concise explanation of the differences between bridging therapy recommendations for non-valvular AF and valvular AF.",
    "axis": "completeness",
    "point": 10
  },
  {
    "criterion": "Fails to provide any guidance on how to integrate the recommended bridging therapy into the patient's overall treatment plan.",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Mentions the need for ongoing monitoring and adjustment of the patient's treatment plan during bridging therapy.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Incorrectly suggests that bridging therapy is only necessary for patients with severe symptoms.",
    "axis": "accuracy",
    "point": -7
  },
  {
    "criterion": "Provides a clear and concise summary of the potential benefits and risks of bridging therapy.",
    "axis": "communication_quality",
    "point": 9
  }
]